dc.contributor.author | Balaban, Muhsin | |
dc.contributor.author | Özkaptan, Orkunt | |
dc.contributor.author | Sevinç, Cüneyd | |
dc.contributor.author | Boz, Mustafa Yücel | |
dc.contributor.author | Horuz, Rahim | |
dc.contributor.author | Kafkaslı, Alper | |
dc.contributor.author | Cangücen, Önder | |
dc.date.accessioned | 2020-01-08T08:18:11Z | |
dc.date.available | 2020-01-08T08:18:11Z | |
dc.date.issued | 2020 | en_US |
dc.identifier.citation | Balaban, M., Özkaptan, O., Sevinç, C., Boz, M. Y., Horuz, R., Kafkaslı, A. ve Cangüven, Ö. (2020). Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases. International Braz J Urol, 46(1), 60-66. https://doi.org/10.1590/S1677-5538.IBJU.2019.0257 | en_US |
dc.identifier.issn | 1677-5538 | |
dc.identifier.issn | 1677-6119 | |
dc.identifier.uri | https://doi.org/10.1590/S1677-5538.IBJU.2019.0257 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/4893 | |
dc.description.abstract | Objectives: To investigate the characteristics of cases of NIH category I acute prostatitis developed after transrectal prostate biopsy and clarifiy the risk factors and preventive factors. Materials and Methods: We retrospectively reviewed the medical records of 3.479 cases of transrectal ultrasound-guided needle biopsies performed with different prophylactic antibiotherapy regimens at two different institutions between January 2011 and February 2016. The patients of Group I have received ciprofloxacin (n=1.523, 500mg twice daily) and the patients of Group II have received ciprofloxacin plus ornidazole (n=1.956, 500mg twice daily) and cleansing enema combination as prophylactic antibiotherapy. The incidence, clinical features and other related microbiological and clinical data, were evaluated. Results: Mean age was 62.38 +/- 7.30 (47-75), and the mean prostate volume was 43.17 +/- 15.20 (21-100) mL. Of the 3.479 patients, 39 (1.1%) developed acute prostatitis after the prostate biopsy procedure. Of the 39 cases of acute prostatitis, 28/3.042 occurred after the first biopsy and 11/437 occurred after repeat biopsy (p=0.038). In Group I, 22 of 1.523 (1.4%) patients developed acute prostatitis. In Group II, 17 of 1.959 (0.8%) patients developed acute prostatitis. There was no statistical difference between the two groups according to acute prostatitis rates (X2=2.56, P=0.11). Further, hypertension or DM were not related to the development of acute prostatitis (P=0.76, X2=0.096 and P=0.83, X2=0.046, respectively). Conclusions: Repeat biopsy seems to increase the risk of acute prostatitis, while the use of antibiotics effective for anaerobic pathogens seems not to be essential yet. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Brazilian Society of Urology | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Acute Bacterial Prostatitis | en_US |
dc.subject | Spectrum Beta-Lactamase | en_US |
dc.subject | Antibiotic-Prophylaxis | en_US |
dc.subject | Needle-Bopsy | en_US |
dc.subject | Anaerobic Infection | en_US |
dc.subject | Single | en_US |
dc.subject | Fluoroquinolone | en_US |
dc.subject | Complications | en_US |
dc.subject | Resistance | en_US |
dc.title | Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases | en_US |
dc.type | article | en_US |
dc.relation.ispartof | International Braz J Urol | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalı | en_US |
dc.authorid | 0000-0002-0159-2090 | en_US |
dc.authorid | 0000-0001-8014-2321 | en_US |
dc.identifier.volume | 46 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 60 | en_US |
dc.identifier.endpage | 66 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.doi | 10.1590/S1677-5538.IBJU.2019.0257 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.identifier.scopusquality | Q3 | en_US |